knowledge -WSS

knowledge

author：entertainment 2025-08-26 10:52:14 - browse：874

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Guidelines to prevent youth baseball injuries need more muscle

WSS

How neuroscience research could help beat back brain cancer

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

As demand for Covid shots wanes, Moderna seeks its next success

Peter Hotez and the public health issue of online harassment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Hollywood unions extend contract negotiations for actors

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The high cost of giving birth even with insurance

Bill would allow buprenorphine prescription for addiction via telehealth

Walensky prepares to leave CDC — and Congress — behind

The cancer drug shortage isn’t new — and neither are the solutions

Duchenne breakthrough therapy leaves behind pioneering families

The health care issue Democrats can’t solve: hospital reform

After affirmative action ruling, medical educators look to 'holistic review'

Duchenne breakthrough therapy leaves behind pioneering families

leisure time

Guidelines to prevent youth baseball injuries need more muscle

After Sarepta trial failure, Duchenne families brace for more debate

Apple is now the first public company to be valued at $3 trillion

Live blog: Hearing on CRISPR

Lung cancer screening guidelines updated for cigarette smokers

State Dept. review finds Biden bears some blame for Afghanistan failures

hotspot

hotspot

explore

leisure time